10 likes | 124 Vues
This document outlines the structure and key personnel within the Board of Directors and various departments dedicated to ensuring compliance, regulation, and safety in pharmaceuticals. Key figures include Mats Larson (Chairman) and Christina Åkerman (Director of Internal Audit), alongside department leads in Strategic Planning, Finance, Human Resources, Legal Affairs, and more. The text emphasizes the importance of adherence to regulations, evaluation of efficacy and safety, and oversight of clinical trials, medicinal products, and pharmaceuticals.
E N D
Board of Directors Mats Larson, chairman InternalAudit Director General Christina Åkerman StrategicPlanning and Security Management Secretariat Finance and Budget Human Resources Eva-Britt Örtegren Administration Enrique Arias Human Resources Information Technology Registration and Information Management Legal Affairs Joakim Brandberg Legal Affairs Facilities and Services Scientific and RegulatoryStrategies Bengt Wittgren (acting) Evaluation and Regulatory Administration Thomas Uhlin (acting) Efficacy and Safety 1 Efficacy and Safety 2 Efficacy and Safety 3 Efficacy and Safety 4 Pharma- ceutics and Bio- technology Product Informa- tion Regulatory Administra- tion Pharmaco- vigilance Herbal Medicinal Products Clinical Trials and Special Permissions Supervision and Scientific Information Karin Hååg (acting) Swedish Poisons Information Centre Medical Devices Cosmetics Supervision of Narcotics and Unauthorised Medicinal Products RationalUse of Medicines Drug Inspectorate Official Medicines Control Laboratory